-+ 0.00%
-+ 0.00%
-+ 0.00%
According to the Zhitong Finance App, Lee's Pharmaceutical Company (00950.HK) issued an announcement. On November 18, 2026 (after the transaction period), the buyer (an indirect wholly-owned subsidiary of the Company) placed a purchase order with the seller to purchase the equipment, at a maximum cost of US$76.684 million (equivalent to approximately HK$598.14 million).
Share
Listen to the news
According to the Zhitong Finance App, Lee's Pharmaceutical Company (00950.HK) issued an announcement. On November 18, 2026 (after the transaction period), the buyer (an indirect wholly-owned subsidiary of the Company) placed a purchase order with the seller to purchase the equipment, at a maximum cost of US$76.684 million (equivalent to approximately HK$598.14 million).
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending